Paulson Richard A. (CIK 0001804460)

Latest company ownership

Shares held
198,331
Last filed at
Oct 16, 2025
Confidence Score
55.4
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 12, 2025 Sep 16, 2025 Karyopharm Therapeutics Inc. CEO Sell 77.5 +1,543 1.87% ✗ $8.1K
May 6, 2025 May 7, 2025 Karyopharm Therapeutics Inc. CEO Sell 52.5 -236 -0.29% ✗ $1.7K
Apr 4, 2025 Apr 7, 2025 Karyopharm Therapeutics Inc. CEO Sell 52.5 -245 -0.30% ✗ $916.3
Mar 4, 2025 Mar 6, 2025 Karyopharm Therapeutics Inc. CEO Sell 42.5 -11,694 -12.35% ✗ $73.6K
Feb 4, 2025 Feb 5, 2025 Karyopharm Therapeutics Inc. CEO Sell 52.5 -4,099 -0.36% ✗ $2.7K
Jan 6, 2025 Jan 7, 2025 Karyopharm Therapeutics Inc. CEO Sell 52.5 -4,055 -0.36% ✗ $3.2K
Dec 4, 2024 Dec 5, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,620 -0.32% ✗ $2.9K
Nov 5, 2024 Nov 6, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,675 -0.32% ✗ $3.3K
Oct 4, 2024 Oct 7, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,607 -0.32% ✗ $3.2K
Sep 4, 2024 Sep 5, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,667 -0.32% ✗ $2.6K
Aug 6, 2024 Aug 8, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,608 -0.31% ✗ $3.4K
Jul 5, 2024 Jul 9, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,616 -0.31% ✗ $3.1K
Jun 4, 2024 Jun 6, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,592 -0.31% ✗ $3.6K
May 6, 2024 May 7, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,576 -0.31% ✗ $4K
Apr 4, 2024 Apr 5, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,563 -0.31% ✗ $4.6K
Mar 5, 2024 Mar 6, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,573 -0.31% ✗ $4.6K
Feb 29, 2024 Mar 4, 2024 Karyopharm Therapeutics Inc. CEO Sell 42.5 -99,844 -7.90% ✗ $117.4K
Feb 6, 2024 Feb 8, 2024 Karyopharm Therapeutics Inc. CEO Sell 52.5 -4,012 -0.49% ✗ $6.4K
Jan 4, 2024 Jan 8, 2024 Karyopharm Therapeutics Inc. CEO Sell 50.0 -4,114 -0.52% ✗ $3.4K
Dec 4, 2023 Dec 5, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,622 -0.46% ✗ $2.9K
Nov 6, 2023 Nov 7, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,606 -0.45% ✗ $3.3K
Oct 4, 2023 Oct 5, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,589 -0.45% ✗ $4.6K
Sep 5, 2023 Sep 6, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,622 -0.45% ✗ $4.8K
Aug 7, 2023 Aug 8, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,722 -0.46% ✗ $6.4K
Jul 5, 2023 Jul 6, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,538 -0.44% ✗ $6.1K
Jun 5, 2023 Jun 7, 2023 Karyopharm Therapeutics Inc. CEO Sell 52.5 -3,536 -0.44% ✗ $7.9K
May 4, 2023 May 5, 2023 Karyopharm Therapeutics Inc. CEO Sell 51.3 -3,805 -0.47% ✗ $12.8K
Apr 4, 2023 Apr 5, 2023 Karyopharm Therapeutics Inc. CEO Sell 51.3 -3,497 -0.43% ✗ $13.9K
Mar 6, 2023 Mar 7, 2023 Karyopharm Therapeutics Inc. CEO Sell 51.3 -3,506 -0.43% ✗ $11.1K
Feb 28, 2023 Mar 2, 2023 Karyopharm Therapeutics Inc. CEO Sell 95.0 +218,967 36.21% ✗ $100.1K
Feb 6, 2023 Feb 8, 2023 Karyopharm Therapeutics Inc. CEO Sell 48.8 -3,950 -0.65% ✗ $13.4K
Jan 4, 2023 Jan 5, 2023 Karyopharm Therapeutics Inc. CEO Sell 48.8 -3,922 -0.64% ✗ $12.8K
Dec 5, 2022 Dec 6, 2022 Karyopharm Therapeutics Inc. CEO Sell 48.8 -3,490 -0.57% ✗ $18K
Nov 4, 2022 Nov 8, 2022 Karyopharm Therapeutics Inc. CEO Sell 48.8 -3,493 -0.56% ✗ $15.9K
Oct 4, 2022 Oct 5, 2022 Karyopharm Therapeutics Inc. CEO Sell 48.8 -3,488 -0.56% ✗ $20.5K
Sep 8, 2022 Sep 9, 2022 Karyopharm Therapeutics Inc. CEO Sell 48.8 -3,479 -0.56% ✗ $18.2K
Aug 4, 2022 Aug 5, 2022 Karyopharm Therapeutics Inc. CEO Sell 51.3 -2,314 -0.37% ✗ $10.4K
Jul 8, 2022 Jul 11, 2022 Karyopharm Therapeutics Inc. CEO Sell 51.3 -2,115 -0.34% ✗ $10.9K
Jun 7, 2022 Jun 8, 2022 Karyopharm Therapeutics Inc. CEO Sell 51.3 -2,542 -0.40% ✗ $14.6K
May 4, 2022 May 5, 2022 Karyopharm Therapeutics Inc. CEO Sell 42.5 -28,502 -4.31% ✗ $177.5K